Total Funding
92
85
Total FundingPost-IPO Equity raised
Growth Score
-6 pts
Heat Score
15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1404
Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.
- Shaun P. Brothers: Co-Founder and Consulting Head of Scientific ResearchPast Role: DemeRx, Director Preclinical Research
- Alexander Rosén: Chief Administrative OfficerPast Role: X-Vax Technology, Head of Administration and Office Management
About the Company
Jupiter Neurosciences is a clinical-stage pharmaceutical company focused on the research and development of therapeutics targeting neuroinflammation and central nervous system disorders. The company conducts clinical trials, including studies for neurological conditions such as Parkinson’s disease and other rare disorders. Jupiter Neurosciences
services include drug discovery and development using a proprietary resveratrol-based platform designed to improve bioavailability and therapeutic delivery.
